187 related articles for article (PubMed ID: 23791500)
1. pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma.
Wang Y; Chen H; Liu Y; Wu J; Zhou P; Wang Y; Li R; Yang X; Zhang N
Biomaterials; 2013 Sep; 34(29):7181-90. PubMed ID: 23791500
[TBL] [Abstract][Full Text] [Related]
2. Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma.
Zhang C; An T; Wang D; Wan G; Zhang M; Wang H; Zhang S; Li R; Yang X; Wang Y
J Control Release; 2016 Mar; 226():193-204. PubMed ID: 26896737
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive pullulan-based nanoparticle carrier for adriamycin to overcome drug-resistance of cancer cells.
Guo H; Liu Y; Wang Y; Wu J; Yang X; Li R; Wang Y; Zhang N
Carbohydr Polym; 2014 Oct; 111():908-17. PubMed ID: 25037431
[TBL] [Abstract][Full Text] [Related]
4. Core-shell nanoparticles based on pullulan and poly(β-amino) ester for hepatoma-targeted codelivery of gene and chemotherapy agent.
Liu Y; Wang Y; Zhang C; Zhou P; Liu Y; An T; Sun D; Zhang N; Wang Y
ACS Appl Mater Interfaces; 2014; 6(21):18712-20. PubMed ID: 25289563
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of combretastatin A4 nanoparticles and sorafenib for systemic therapy of hepatocellular carcinoma.
Wang Y; Yu H; Zhang D; Wang G; Song W; Liu Y; Ma S; Tang Z; Liu Z; Sakurai K; Chen X
Acta Biomater; 2019 Jul; 92():229-240. PubMed ID: 31100462
[TBL] [Abstract][Full Text] [Related]
6. Efficient Delivery of DOX to Nuclei of Hepatic Carcinoma Cells in the Subcutaneous Tumor Model Using pH-Sensitive Pullulan-DOX Conjugates.
Li H; Cui Y; Sui J; Bian S; Sun Y; Liang J; Fan Y; Zhang X
ACS Appl Mater Interfaces; 2015 Jul; 7(29):15855-65. PubMed ID: 26140410
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of combretastatin A4 nanoparticles and anti-PD-L1 for synergistic therapy of hepatocellular carcinoma.
Zhao B; Dong Z; Liu W; Lou F; Wang Q; Hong H; Wang Y
J Nanobiotechnology; 2021 May; 19(1):124. PubMed ID: 33933077
[TBL] [Abstract][Full Text] [Related]
8. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma.
Wang Y; Liu Y; Liu Y; Zhou W; Wang H; Wan G; Sun D; Zhang N; Wang Y
Int J Pharm; 2015 Apr; 483(1-2):89-100. PubMed ID: 25681730
[TBL] [Abstract][Full Text] [Related]
9. Pullulan-coated phospholipid and Pluronic F68 complex nanoparticles for carrying IR780 and paclitaxel to treat hepatocellular carcinoma by combining photothermal therapy/photodynamic therapy and chemotherapy.
Wang D; Zhang S; Zhang T; Wan G; Chen B; Xiong Q; Zhang J; Zhang W; Wang Y
Int J Nanomedicine; 2017; 12():8649-8670. PubMed ID: 29255359
[TBL] [Abstract][Full Text] [Related]
10. Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells.
Balasso A; Salmaso S; Pontisso P; Rosato A; Quarta S; Malfanti A; Mastrotto F; Caliceti P
Eur J Pharm Sci; 2017 May; 103():104-115. PubMed ID: 28192167
[TBL] [Abstract][Full Text] [Related]
11. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
12. Effect of modification manner on the photodynamic antitumor activity of C60 modified with pullulan.
Liu J; Tabata Y
J Biomater Sci Polym Ed; 2011; 22(16):2147-63. PubMed ID: 21902907
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
Zhang L; Yao J; Zhou J; Wang T; Zhang Q
Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
[TBL] [Abstract][Full Text] [Related]
14. pH- and redox-responsive nanoparticles composed of charge-reversible pullulan-based shells and disulfide-containing poly(ß-amino ester) cores for co-delivery of a gene and chemotherapeutic agent.
Zhang S; Wang D; Li Y; Li L; Chen H; Xiong Q; Liu Y; Wang Y
Nanotechnology; 2018 Aug; 29(32):325101. PubMed ID: 29761789
[TBL] [Abstract][Full Text] [Related]
15. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
[TBL] [Abstract][Full Text] [Related]
16. High drug loading pH-sensitive pullulan-DOX conjugate nanoparticles for hepatic targeting.
Li H; Bian S; Huang Y; Liang J; Fan Y; Zhang X
J Biomed Mater Res A; 2014 Jan; 102(1):150-9. PubMed ID: 23613258
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma.
Cheng XL; Zhou TY; Li B; Li MY; Li L; Li ZQ; Lu W
Acta Pharmacol Sin; 2013 Jul; 34(7):951-9. PubMed ID: 23603981
[TBL] [Abstract][Full Text] [Related]
18. Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma.
Xu L; Wu S; Zhou X
J Biomater Appl; 2018 Jul; 33(1):72-81. PubMed ID: 29699442
[TBL] [Abstract][Full Text] [Related]
19. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
Taheri A; Dinarvand R; Ahadi F; Khorramizadeh MR; Atyabi F
Int J Pharm; 2012 Jul; 431(1-2):183-9. PubMed ID: 22531853
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101.
Bao X; Shen N; Lou Y; Yu H; Wang Y; Liu L; Tang Z; Chen X
Theranostics; 2021; 11(12):5955-5969. PubMed ID: 33897892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
